+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atorvastatin Market by Product Type (Branded, Generic), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, Application, Form - Global Forecast 2025-2030- Product Image
Atorvastatin Market by Product Type (Branded, Generic), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, Application, Form - Global Forecast 2025-2030- Product Image
Sale

Atorvastatin Market by Product Type (Branded, Generic), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, Application, Form - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967610
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The atorvastatin market is experiencing growth as healthcare providers prioritize advanced cardiovascular risk management solutions and adapt to complex regulatory and competitive environments. This progress is propelled by shifting treatment protocols, increased demand for patient access, and ongoing innovation across production and distribution networks.

Market Snapshot: Atorvastatin Market Trajectory and Growth Outlook

The Atorvastatin Market grew from USD 1.32 billion in 2024 to USD 1.40 billion in 2025. It is expected to continue growing at a CAGR of 5.22%, reaching USD 1.80 billion by 2030. This upward trajectory underscores consistent demand, steady adoption of statin therapies, and the increasing integration of atorvastatin into healthcare systems globally. Market expansion is underpinned by both branded and generic product launches, tailored patient approaches, and a dynamic supply chain adapting to regulatory evolution.

Scope & Segmentation

  • Product Type: Branded products and generic alternatives both shape market strategies and determine healthcare institution purchasing preferences.
  • Distribution Channel: Hospital pharmacies, retail pharmacies, and online pharmacies enable multi-channel access for various patient and provider needs.
  • Dosage Strength: Dosage strengths cover 10 mg, 20 mg, 40 mg, and 80 mg, supporting initial prevention and intensive management scenarios.
  • Application: Key clinical uses include familial hypercholesterolemia, mixed dyslipidemia, and primary hypercholesterolemia, each with unique management protocols and monitoring requirements.
  • Form: Capsule and tablet formats allow flexibility for different markets and support preferences for release profiles or cost-sensitivity.
  • Region:
    • Americas: United States and major states, Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, and various regional economies
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Southeast Asian nations
  • Leading Companies: Major manufacturers and innovators include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Lupin Limited, Cipla Limited, and Apotex Inc.

Key Takeaways for Senior Decision-Makers

  • Atorvastatin remains central to lipid management as practitioners seek reliable, clinically established solutions for cardiovascular disease prevention and progression management.
  • The increased availability of generics fosters broad patient access and compels branded producers to differentiate through service, formulation enhancements, and outcome-based programs.
  • Combination therapies and personalized dosing approaches are gaining momentum in efforts to reduce residual risk and improve adherence across diverse patient cohorts.
  • Operational agility is required as healthcare regulations and reimbursement structures become more intricate, especially across emerging and established markets.
  • Digital health tools, including remote monitoring and adherence support, are becoming critical differentiators in strengthening patient engagement and capturing real-world data.
  • Strategic collaborations between API suppliers, manufacturers, and distribution partners streamline processes and address evolving policy, supply, and competition challenges.

Tariff Impact: Navigating Cost and Supply Chain Adjustments in the United States

The 2025 tariff regime in the United States has introduced new cost pressures across the atorvastatin supply chain by targeting specific imported pharmaceutical ingredients. Manufacturers are pivoting toward domestic partnerships, strengthening buffer stocks, and diversifying shipping routes to offset disruptions and stabilize pricing structures. These measures foster greater supply chain resilience and underline the critical role of adaptive procurement strategies in protecting access and market share.

Methodology & Data Sources

This report incorporates primary research through in-depth interviews with industry experts and secondary research using peer-reviewed literature and regulatory filings. Analytical frameworks employed include PESTEL, Porter’s Five Forces, and SWOT analysis, with comprehensive value chain mapping and data triangulation for validation. Every conclusion is reviewed to ensure alignment with current market realities and industry practices.

Why This Report Matters

  • Empowers executive decision-makers to anticipate regulatory, clinical, and market shifts—enabling robust strategic planning.
  • Delivers actionable segmentation and competitor intelligence, helping organizations benchmark opportunities and mitigate emerging risks.
  • Provides in-depth analysis of regional and channel-specific variations, equipping stakeholders to optimize product portfolios and market expansion strategies.

Conclusion

The atorvastatin market continues to evolve under the influence of clinical advances, regulatory changes, and competitive activity. Companies that invest in operational flexibility and stakeholder collaboration are better positioned to capture value and contribute to improved cardiovascular outcomes worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing competition from authorized generic atorvastatin driving price compression and margin pressure
5.2. Adoption of fixed-dose combination therapies pairing atorvastatin with novel lipid-lowering agents to improve patient outcomes
5.3. Regulatory guidance updates on LDL-C targets boosting demand for high-intensity atorvastatin dosing regimens
5.4. Expansion of direct-to-consumer digital adherence solutions targeting atorvastatin patients to reduce discontinuation rates
5.5. Emerging market growth for atorvastatin driven by government bulk procurement and generic substitution policies
5.6. Strategic partnerships between pharmaceutical companies and telehealth platforms to streamline atorvastatin therapy management
5.7. Manufacturing innovations in nanoparticle delivery systems aiming to enhance atorvastatin bioavailability and stability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Atorvastatin Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Atorvastatin Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Atorvastatin Market, by Dosage Strength
10.1. Introduction
10.2. 10 mg
10.3. 20 mg
10.4. 40 mg
10.5. 80 mg
11. Atorvastatin Market, by Application
11.1. Introduction
11.2. Familial Hypercholesterolemia
11.3. Mixed Dyslipidemia
11.4. Primary Hypercholesterolemia
12. Atorvastatin Market, by Form
12.1. Introduction
12.2. Capsule
12.3. Tablet
13. Americas Atorvastatin Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Atorvastatin Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Atorvastatin Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Viatris Inc.
16.3.4. Sandoz International GmbH
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Dr. Reddy's Laboratories Ltd.
16.3.7. Aurobindo Pharma Limited
16.3.8. Lupin Limited
16.3.9. Cipla Limited
16.3.10. Apotex Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ATORVASTATIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ATORVASTATIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ATORVASTATIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ATORVASTATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ATORVASTATIN MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ATORVASTATIN MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ATORVASTATIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ATORVASTATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ATORVASTATIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ATORVASTATIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ATORVASTATIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ATORVASTATIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ATORVASTATIN MARKET: RESEARCHAI
FIGURE 26. ATORVASTATIN MARKET: RESEARCHSTATISTICS
FIGURE 27. ATORVASTATIN MARKET: RESEARCHCONTACTS
FIGURE 28. ATORVASTATIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ATORVASTATIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ATORVASTATIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ATORVASTATIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ATORVASTATIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ATORVASTATIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ATORVASTATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ATORVASTATIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ATORVASTATIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ATORVASTATIN MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ATORVASTATIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ATORVASTATIN MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ATORVASTATIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ATORVASTATIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ATORVASTATIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ATORVASTATIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ATORVASTATIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ATORVASTATIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ATORVASTATIN MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ATORVASTATIN MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ATORVASTATIN MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ATORVASTATIN MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ATORVASTATIN MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ATORVASTATIN MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ATORVASTATIN MARKET SIZE, BY 80 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ATORVASTATIN MARKET SIZE, BY 80 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ATORVASTATIN MARKET SIZE, BY FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ATORVASTATIN MARKET SIZE, BY FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ATORVASTATIN MARKET SIZE, BY MIXED DYSLIPIDEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ATORVASTATIN MARKET SIZE, BY MIXED DYSLIPIDEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ATORVASTATIN MARKET SIZE, BY PRIMARY HYPERCHOLESTEROLEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ATORVASTATIN MARKET SIZE, BY PRIMARY HYPERCHOLESTEROLEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ATORVASTATIN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ATORVASTATIN MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ATORVASTATIN MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ATORVASTATIN MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ATORVASTATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ATORVASTATIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES ATORVASTATIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES ATORVASTATIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 71. CANADA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 72. CANADA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 73. CANADA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. CANADA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. CANADA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 76. CANADA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 77. CANADA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. CANADA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. CANADA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 80. CANADA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 81. MEXICO ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. MEXICO ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. MEXICO ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 86. MEXICO ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 87. MEXICO ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. MEXICO ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. MEXICO ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 90. MEXICO ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ATORVASTATIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 133. GERMANY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. GERMANY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. GERMANY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. GERMANY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. GERMANY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 138. GERMANY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 139. GERMANY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. GERMANY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. GERMANY ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 142. GERMANY ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 143. FRANCE ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. FRANCE ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. FRANCE ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. FRANCE ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. FRANCE ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. FRANCE ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. FRANCE ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. FRANCE ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. FRANCE ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 152. FRANCE ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 163. ITALY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. ITALY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. ITALY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ITALY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ITALY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 168. ITALY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 169. ITALY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ITALY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ITALY ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 172. ITALY ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 173. SPAIN ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. SPAIN ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. SPAIN ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. SPAIN ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. SPAIN ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 178. SPAIN ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 179. SPAIN ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. SPAIN ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. SPAIN ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 182. SPAIN ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 213. DENMARK ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. DENMARK ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. DENMARK ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. DENMARK ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. DENMARK ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 218. DENMARK ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 219. DENMARK ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. DENMARK ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. DENMARK ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 222. DENMARK ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 233. QATAR ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. QATAR ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. QATAR ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. QATAR ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. QATAR ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. QATAR ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. QATAR ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. QATAR ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. QATAR ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 242. QATAR ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 243. FINLAND ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. FINLAND ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. FINLAND ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. FINLAND ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. FINLAND ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. FINLAND ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. FINLAND ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FINLAND ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FINLAND ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 252. FINLAND ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 273. EGYPT ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. EGYPT ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. EGYPT ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. EGYPT ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. EGYPT ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 278. EGYPT ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 279. EGYPT ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. EGYPT ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. EGYPT ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 282. EGYPT ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 283. TURKEY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. TURKEY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. TURKEY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. TURKEY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. TURKEY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 288. TURKEY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 289. TURKEY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. TURKEY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. TURKEY ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 292. TURKEY ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 303. NORWAY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. NORWAY ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. NORWAY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NORWAY ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NORWAY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 308. NORWAY ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 309. NORWAY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. NORWAY ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. NORWAY ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 312. NORWAY ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 313. POLAND ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. POLAND ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. POLAND ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. POLAND ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. POLAND ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. POLAND ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. POLAND ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. POLAND ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. POLAND ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 322. POLAND ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 323. SWITZERLAND ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 324. SWITZERLAND ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 342. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 344. ASIA-PACIFIC ATORVASTATIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 345. CHINA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. CHINA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. CHINA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 348. CHINA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 349. CHINA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 350. CHINA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 351. CHINA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 352. CHINA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 353. CHINA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 354. CHINA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 355. INDIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 356. INDIA ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 357. INDIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 358. INDIA ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 359. INDIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 360. INDIA ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 361. INDIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 362. INDIA ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 363. INDIA ATORVASTATIN MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 364. INDIA ATORVASTATIN MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 365. JAPAN ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 366. JAPAN ATORVASTATIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 367. JAPAN ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 368. JAPAN ATORVASTATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 369. JAPAN ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 370. JAPAN ATORVASTATIN MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 371. JAPAN ATORVASTATIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 372. JAPAN ATORVASTATIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 373. JAPAN ATORVASTATIN MARKET SIZE, BY FORM, 201

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Atorvastatin market report include:
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma Limited
  • Lupin Limited
  • Cipla Limited
  • Apotex Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.8 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Atorvastatin Intermediate L-1 Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Atorvastatin Intermediate L-1 Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 81 Pages
  • Global
From
Atorvastatin Calcium Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Atorvastatin Calcium Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 80 Pages
  • Global
From
Atorvastatin Market Report 2025 - Product Image

Atorvastatin Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Atorvastatin (CAS 134523-00-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Atorvastatin (CAS 134523-00-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Ezetimibe Combination Medications Market by Product (Atorvastatin Ezetimibe, Rosuvastatin Ezetimibe, Simvastatin Ezetimibe), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Strength, Dosage Form - Global Forecast 2025-2030 - Product Image

Ezetimibe Combination Medications Market by Product (Atorvastatin Ezetimibe, Rosuvastatin Ezetimibe, Simvastatin Ezetimibe), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Strength, Dosage Form - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From

About the Atorvastatin Market

Atorvastatin is a drug used to treat high cholesterol and other lipid disorders. It belongs to a class of drugs known as statins, which are used to reduce the risk of cardiovascular disease. Atorvastatin works by blocking an enzyme in the liver that is responsible for producing cholesterol. This reduces the amount of cholesterol in the blood, which can help reduce the risk of heart attack and stroke. Atorvastatin is available in both generic and brand-name forms. It is typically prescribed in combination with lifestyle changes such as diet and exercise. Atorvastatin is one of the most widely prescribed drugs for cardiovascular disease. It is used to treat a variety of conditions, including high cholesterol, coronary artery disease, and stroke. It is also used to reduce the risk of heart attack and stroke in people with diabetes. The atorvastatin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, Merck, AstraZeneca, and Novartis. Other companies include Mylan, Teva, and Sandoz. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.